Published online before print April 30, 2007, doi: 10.1161/CIRCULATIONAHA.106.657627
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2007;115:2526-2532.)
© 2007 American Heart Association, Inc.
Pediatric Cardiology |
Serum Concentrations of Uric Acid and the Metabolic Syndrome Among US Children and Adolescents
From the Division of Adult and Community Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Ga (E.S.F, C.L.); Strong Children’s Research Center, Department of Pediatrics, University of Rochester School of Medicine and Dentistry, Rochester, NY (S.C.); and Rheumatology Division, Arthritis Research Centre of Canada, Department of Medicine, Vancouver General Hospital, University of British Columbia, Vancouver, Canada, and Channing Laboratory, Renal Division, Department of Medicine, Brigham and Women’s Hospital, Boston, Mass (H.K.C.).
Correspondence to Earl S. Ford, MD, MPH, Centers for Disease Control and Prevention, 4770 Buford Hwy, MS K66, Atlanta, GA 30341. E-mail eford{at}cdc.gov
Received October 4, 2006; accepted March 19, 2007.
Background— The association between concentrations of uric acid and the metabolic syndrome in children and adolescents remains incompletely understood. The objective of this study was to examine how these 2 were associated in a nationally representative sample of US children and adolescents.
Methods and Results— We performed a cross-sectional analysis of 1370 males and females aged 12 to 17 years using data from the National Health and Nutrition Examination Survey 1999–2002. The prevalence of the metabolic syndrome was <1% among participants in the lowest quartile of serum concentration of uric acid, 3.7% in the second quartile, 10.3% in the third quartile, and 21.1% in the highest quartile. Compared with the lowest 2 quartiles of uric acid together (
291.5 µmol/L), the odds ratios were 5.80 (95% confidence interval, 3.22 to 10.46) for those in the third quartile (>291.5 to 339 µmol/L or >4.9 to 5.7 mg/dL) and 14.79 (95% confidence interval, 7.78 to 28.11) for those in the top quartile (>339 µmol/L) after adjustment for age, sex, race or ethnicity, and concentrations of C-reactive protein. Starting with the lowest quartile of concentration of uric acid, mean concentrations of serum insulin were 66.2, 66.7, 79.9, and 90.9 pmol/L for ascending quartiles, respectively (P for trend <0.001).
Conclusions— Among US children and adolescents, serum concentrations of uric acid are strongly associated with the prevalence of the metabolic syndrome and several of its components.
CLINICAL PERSPECTIVE
This article has been cited by other articles:
 |
|
 |
|
  L.-C. SEE, C.-F. KUO, F.-H. CHUANG, H.-Y. LI, Y.-M. CHEN, H.-W. CHEN, and K.-H. YU Serum Uric Acid Is Independently Associated with Metabolic Syndrome in Subjects with and without a Low Estimated Glomerular Filtration Rate J Rheumatol, August 1, 2009; 36(8): 1691 - 1698. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Jiao, A. Flood, A. F. Subar, A. R. Hollenbeck, A. Schatzkin, and R. Stolzenberg-Solomon Glycemic Index, Carbohydrates, Glycemic Load, and the Risk of Pancreatic Cancer in a Prospective Cohort Study Cancer Epidemiol. Biomarkers Prev., April 1, 2009; 18(4): 1144 - 1151. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. D. Johnson, J. J. M. Kroon, F. L. Greenway, C. Bouchard, D. Ryan, and P. T. Katzmarzyk Prevalence of Risk Factors for Metabolic Syndrome in Adolescents: National Health and Nutrition Examination Survey (NHANES), 2001-2006 Arch Pediatr Adolesc Med, April 1, 2009; 163(4): 371 - 377. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. Johnson, S. E. Perez-Pozo, Y. Y. Sautin, J. Manitius, L. G. Sanchez-Lozada, D. I. Feig, M. Shafiu, M. Segal, R. J. Glassock, M. Shimada, et al. Hypothesis: Could Excessive Fructose Intake and Uric Acid Cause Type 2 Diabetes? Endocr. Rev., February 1, 2009; 30(1): 96 - 116. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Pacifico, V. Cantisani, C. Anania, E. Bonaiuto, F. Martino, R. Pascone, and C. Chiesa Serum uric acid and its association with metabolic syndrome and carotid atherosclerosis in obese children Eur. J. Endocrinol., January 1, 2009; 160(1): 45 - 52. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Groesbeck, A. Kottgen, R. Parekh, E. Selvin, G. J. Schwartz, J. Coresh, and S. Furth Age, Gender, and Race Effects on Cystatin C Levels in US Adolescents Clin. J. Am. Soc. Nephrol., November 1, 2008; 3(6): 1777 - 1785. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. I. Feig, D.-H. Kang, and R. J. Johnson Uric Acid and Cardiovascular Risk N. Engl. J. Med., October 23, 2008; 359(17): 1811 - 1821. [Full Text] [PDF]
|
|
|
|
 |
|
 A. Brandstatter, S. Kiechl, B. Kollerits, S. C. Hunt, I. M. Heid, S. Coassin, J. Willeit, T. D. Adams, T. Illig, P. N. Hopkins, et al. Sex-Specific Association of the Putative Fructose Transporter SLC2A9 Variants With Uric Acid Levels Is Modified by BMI Diabetes Care, August 1, 2008; 31(8): 1662 - 1667. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Douard and R. P. Ferraris Regulation of the fructose transporter GLUT5 in health and disease Am J Physiol Endocrinol Metab, August 1, 2008; 295(2): E227 - E237. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. E. Weiner, H. Tighiouart, E. F. Elsayed, J. L. Griffith, D. N. Salem, and A. S. Levey Uric Acid and Incident Kidney Disease in the Community J. Am. Soc. Nephrol., June 1, 2008; 19(6): 1204 - 1211. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. G. Sanchez-Lozada, E. Tapia, P. Bautista-Garcia, V. Soto, C. Avila-Casado, I. P. Vega-Campos, T. Nakagawa, L. Zhao, M. Franco, and R. J. Johnson Effects of febuxostat on metabolic and renal alterations in rats with fructose-induced metabolic syndrome Am J Physiol Renal Physiol, April 1, 2008; 294(4): F710 - F718. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J Johnson, M. S Segal, Y. Sautin, T. Nakagawa, D. I Feig, D.-H. Kang, M. S Gersch, S. Benner, and L. G Sanchez-Lozada Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease Am. J. Clinical Nutrition, October 1, 2007; 86(4): 899 - 906. [Abstract] [Full Text] [PDF]
|
|